PEG-IFN in HBV Patients With Incomplete Response to NA
NCT00883844
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
Nucleos(t)ide analogue treatment with a peginterferon add-on strategy
DRUG:
Nucleos(t)ide analogue treatment
Sponsor
Foundation for Liver Research